## IQV: IQVIA Holdings Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.96 indicates fundamental undervaluation. Quality metrics strong (ROE 19%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (36% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($217.09)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Cwm LLC Raises Stock Holdings in IQVIA Holdings Inc. $IQV**
- Source: MarketBeat | 20251230T093414 | Bullish | Relevance: 100%
- Cwm LLC significantly increased its stake in IQVIA Holdings Inc. by 37.8% in Q3, purchasing an additional 12,363 shares and bringing its total holdings to 45,068 shares valued at approximately $8.56 million. IQVIA exceeded Q3 expectations with $3.00 EPS on revenues of $4.10 billion, and analysts widely rate the stock as a "Moderate Buy" with an average target price of $243.19. Institutional investors hold a substantial 89.62% of IQVIA, while insiders, despite a recent sale by Eric Sherbet, retain 1.60% ownership.

**2. Here's Why You Should Retain IQV Stock in Your Portfolio Now**
- Source: Finviz | 20251230T000807 | Bullish | Relevance: 100%
- IQVIA Holdings, Inc. (IQV) exhibits strong potential for retention in portfolios due to its collaboration with Amazon Web Services enhancing its AI capabilities in life sciences, a robust R&DS backlog, and a commitment to shareholder returns through share repurchases. Despite these strengths, the company faces significant challenges with its liquidity, as indicated by a consistently falling current ratio. IQVIA currently holds a Zacks Rank of #3 (Hold), with other stocks like Byrna Technologies (BYRN) and Veralto Corporation (VLTO) receiving higher ranks.

**3. Here's Why You Should Retain IQV Stock in Your Portfolio Now**
- Source: TradingView â€” Track All Markets | 20251229T180804 | Somewhat-Bullish | Relevance: 97%
- IQVIA (IQV) stock has outperformed its industry significantly, driven by an expected long-term EPS growth rate of 8.38% and strong collaborations with Amazon Web Services ("AWS") for AI integration in life sciences. The company shows robust revenue visibility with a growing R&DS backlog and active share repurchase programs. However, challenges include a consistently falling current ratio, indicating liquidity concerns.

**4. Marathon Asset Management Ltd Sells 40,797 Shares of IQVIA Holdings Inc. $IQV**
- Source: MarketBeat | 20251229T113232 | Somewhat-Bullish | Relevance: 97%
- Marathon Asset Management Ltd has reduced its stake in IQVIA Holdings Inc. (NYSE:IQV) by 24.1%, selling 40,797 shares to hold 128,464 shares valued at $24.4 million. Despite this sale, institutional ownership remains high at 89.62%, and analysts maintain a "Moderate Buy" rating with a consensus price target of $243.19. IQVIA also reported strong Q3 earnings, exceeding estimates and providing positive FY2025 guidance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $265 | $250 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($1.46M) |
| Sells | 2 ($4.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (-0.9%)
- Blackrock Inc.: 8.7% (+4.5%)
- Harris Associates L.: 6.7% (-3.1%)
- State Street Corpora: 4.4% (-1.0%)
- JPMORGAN CHASE & CO: 3.9% (+110.0%)

### Key Risks

1. Insider selling cluster: $4.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.96 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +6%). Insider selling cluster ($4.6M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.4B |
| Beta | 1.37 |
| 52W Range | $134.65 - $234.30 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.96 |
| Forward P/E | 17.4 |
| Current P/E | 19.0 |
| YoY Growth | 8.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.5% to 1.2% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.8pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54. Volume at 36% of 20MA suggests lack of conviction. OFD pattern: -FTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.18% (CS: 72) | Neutral |
| RSI_14 | 54.2 | Neutral |
| MACD Histogram | -0.00 | Bearish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 1.228x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $225.49
- **Stop Loss:** $217.09 (3.7% risk)
- **Target:** $242.29 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 171
- **Position Value:** $38,558.79
- **Portfolio %:** 38.56%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-02-05 (Est: $3.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.98 | $3.00 | +0.8% |
| 2025Q2 | $2.77 | $2.81 | +1.4% |
| 2025Q1 | $2.63 | $2.70 | +2.6% |
| 2024Q4 | $3.11 | $3.12 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*